[1]
“Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer’s disease: a meta-analysis”, Swiss Med Wkly, vol. 149, no. 2526, p. w20093, Jun. 2019, doi: 10.4414/smw.2019.20093.